TSN and Alzheimer disease: Similar results were obtained in vivo where we observed dysregulation of miR‐181a and translin in the hippocampal synaptosome fraction of 3xTg‐AD mice and failure to restore translin protein levels by inhibiting miR‐181a in the hippocampus of the AD model.